2
项与 Influenza Virus (ST Pharm) 相关的临床试验Randomized, blind and positive control phase II clinical trial to evaluate the immunogenicity and safety of quadrivalent split influenza virus vaccine in healthy subjects aged 6-35 months
Optimalization of the response to influenza virus vaccination in breast cancer and colorectal cancer patients immunocompromised due to chemotherapy - Ofluvac
100 项与 Influenza Virus (ST Pharm) 相关的临床结果
100 项与 Influenza Virus (ST Pharm) 相关的转化医学
100 项与 Influenza Virus (ST Pharm) 相关的专利(医药)
100 项与 Influenza Virus (ST Pharm) 相关的药物交易